12 results
10-K
2023 FY
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Annual report
4:05pm
competitors in Europe. In 2012, the European Patent Package, or the EU Patent Package, regulations were passed with the goal of providing a single pan … successfully launched on June 1, 2023. Under the UPC, all European patents, including those issued prior to ratification of the European Patent Package
424B4
NMRA
Neumora Therapeutics Inc.
18 Sep 23
Prospectus supplement with pricing info
4:12pm
rights against competitors in Europe. In 2012, the European Patent Package, or the EU Patent Package, regulations were passed with the goal … of the European Patent Package, now by default automatically fall under the jurisdiction of the UPC. The UPC provides our competitors with a new forum
S-1/A
EX-1.1
NMRA
Neumora Therapeutics Inc.
11 Sep 23
IPO registration (amended)
6:07am
the following information (collectively with the pricing information set forth on Annex A, the “Pricing Disclosure Package”): a Preliminary Prospectus … forth in the Pricing Disclosure Package. The Company acknowledges and agrees that the Underwriters may offer and sell Shares to or through any affiliate
S-1/A
NMRA
Neumora Therapeutics Inc.
11 Sep 23
IPO registration (amended)
6:07am
and enforce our patent rights against competitors in Europe. In 2012, the European Patent Package, or the EU Patent Package, regulations were passed … prior to ratification of the European Patent Package, now by default automatically fall under the jurisdiction of the UPC. The UPC provides our
S-1
EX-2.1
pc7 ee69u9kdxr4of
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.6
fgv7488lg2zpxe6l zgo
25 Aug 23
IPO registration
5:03pm
S-1
jd2f2183
25 Aug 23
IPO registration
5:03pm
DRS/A
z3bdqu
9 Aug 23
Draft registration statement (amended)
12:00am
DRS/A
f5nyjzeu
30 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
EX-10.7
vtb krv6l7p982nela
30 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
l35xqnz1
2 May 23
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next